Related by context. Frequent words. (Click for all words.) 77 Epratuzumab 76 Pivotal Phase III 75 Pivotal Phase 75 pertuzumab 74 Vandetanib 74 KRN# 74 Irinotecan 74 Cethromycin 74 Dasatinib 74 Bortezomib 73 liposomal formulation 73 elotuzumab 73 multi kinase inhibitor 73 Gemzar ® 73 Panzem R 73 mTOR inhibitor 73 Traficet EN 73 Alemtuzumab 73 Metastatic Melanoma 72 Bevacizumab 72 Amrubicin 72 Nexavar ® 72 phase IIb clinical 72 R sorafenib tablets 72 metastatic hormone refractory 72 axitinib 72 BAY #-# 72 MEK inhibitor 72 Carfilzomib 72 HER2 positive metastatic breast 71 OncoVEX GM CSF 71 PEG SN# 71 Drug Candidate 71 aflibercept 71 Apixaban 71 Clinical Trial Results 71 Mipomersen 71 mRCC 71 Zolinza 71 temsirolimus 71 Pivotal Trial 71 Phase III Clinical Trial 71 Chronic Hepatitis C 71 relapsed multiple myeloma 71 Patient Enrollment 71 Voreloxin 70 Perifosine 70 KNS # 70 orally bioavailable 70 Panitumumab 70 Trastuzumab 70 Rebif ® 70 plus prednisone 70 Pulmonary Arterial Hypertension 70 Erlotinib 70 DDP# 70 Laquinimod 70 GSK# [001] 70 HuMax CD# 70 GLPG# 70 Onalta 70 tocilizumab 70 ocrelizumab 70 Phase III Trial 70 Lenalidomide 70 vorinostat 70 Preclinical Data 70 Monotherapy 70 angiogenesis inhibitor 70 Ofatumumab 70 Imprime PGG 69 Torisel 69 superficial bladder cancer 69 bevacizumab Avastin 69 DOXIL 69 Pirfenidone 69 Clevudine 69 Herceptin trastuzumab 69 ATL# [001] 69 Vilazodone 69 HGS ETR1 69 EndoTAG TM -1 69 Targretin 69 FDA Accepts 69 anticancer compound 69 nab paclitaxel 69 TYKERB 69 atacicept 69 carboplatin paclitaxel 69 Gemcitabine 69 Phase Ib clinical 69 Sorafenib 69 Eltrombopag 69 romidepsin 69 Metastatic Colorectal Cancer 69 methylnaltrexone 69 Presents Positive 69 Completes Enrollment 69 CYC# 69 metastatic renal cell carcinoma 69 Fludara